By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2275 Research Boulevard
Suite 700
Rockville  Maryland  20850  U.S.A.
Phone: 240-238-4900 Fax: 240-238-4901


Accelovance, Inc., based in Rockville, MD, is a clinical services company specializing in high patient throughput from recruitment through study completion. Accelovance has developed a model to increase the reliability and productivity on Phase I (outpatient) and Phase II-IV trials. Accelovance enhances this offering with flexible CRO services to meet a Sponsor’s specific trial needs.

Each study is approached with the intent to complete enrollment BEFORE the study starts. With critical planning and full control of patient recruitment and clinical facility operations, Accelovance is committed to delivering high quality, predictable, and cost effective clinical trials.

Accelovance (China) Corp., Ltd., a wholly foreign owned enterprise of Accelovance, Inc., is a clinical CRO and market commercialization services company with offices in Beijing and Shanghai, P.R. China. Accelovance (China) fully leverages its relationship with its parent company, U.S. to deliver high quality clinical services in compliance with international standards. In addition, Accelovance (China) works with sponsors to realize the value of the China pharmaceutical market, which is the fastest growing in the world.

Key Statistics

Ownership: Private

Web Site: Accelovance


Company News
Accelovance Continues Oncology Leadership Growth With Addition Of Former Global VP, Oncology From Wyeth (WYE)/Pfizer (PFE) And Bayer (BAY) 9/30/2015 6:46:30 AM
Midwest Melanoma Partnership And Accelovance Enhance Melanoma Research Offering Through Strategic Alliance 9/15/2015 6:07:53 AM
Accelovance Will Create 70 Jobs at New European HQ 8/12/2015 7:10:21 AM
Accelovance Completes Trial Enrollment And Delivery Of Clinical Data For Heron (HRTX)' Phase 3 Trial 7/7/2015 9:53:45 AM
Accelovance Expands Capabilities In Europe With Acquisition Of Altair Clinical, Ltd. 2/5/2015 7:40:48 AM
Accelovance Selects USAN’s All-Inclusive Hosted Contact Center Suite for Clinical Research Study 9/24/2013 10:08:23 AM
Accelovance Primed to Achieve Leadership in Oncology Clinical Trials 7/11/2013 9:20:06 AM
Sixth Consecutive "Best CRO" Award Nomination for Accelovance 3/27/2013 9:28:49 AM
Accelovance Expansion Continues With Acquisition of Radiant Development, the CRO Division of Radiant Research 3/7/2013 9:34:22 AM
Accelovance Expands Oncology Leadership With the Addition of Ralph Boccia, MD as Oncology Medical Director 3/1/2013 10:16:26 AM